Similar articles

• Cold-adapted reassortants of influenza A virus: pathogenicity of A/Ann Arbor/6/60 X A/Alaska/6/77 reassortant viruses in vivo and in vitro.

  Heath AW, Maassab HF, Odagiri T, DeBorde DC, Potter CW. Heath AW, et al. Arch Virol. 1986;91(1-2):53-60. doi: 10.1007/BF01316727. Arch Virol. 1986. PMID: 3753204
• [The NS gene--a possible determinant of apathogenicity of a cold-adapted donor of attenuation A /Leningrad/134/47/57 and its reassortants].

  Egorov AIu, Garmashova LM, Lukashok IV, Nevedomskaia GN, Aleksandrova GI, Klimov AI. Egorov AIu, et al. Vopr Virusol. 1994 Sep-Oct;39(5):201-5. Vopr Virusol. 1994. PMID: 7716901 Russian.
• Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine.

  Ghendon YZ, Markushin SG, Akopova II, Koptiaeva IB, Nechaeva EA, Mazurkova LA, Radaeva IF, Kolokoltseva TD. Ghendon YZ, et al. Vaccine. 2005 Sep 7;23(38):4678-84. doi: 10.1016/j.vaccine.2005.04.039. Vaccine. 2005. PMID: 16026905
• Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.

  Lee KH, Seo SU, Song JM, Lee CM, Kim HA, Seong BL. Lee KH, et al. Vaccine. 2006 Mar 10;24(11):1966-74. doi: 10.1016/j.vaccine.2005.10.051. Epub 2005 Nov 8. Vaccine. 2006. PMID: 16343703
• [Live cold-adapted influenza vaccine: state-of-the-art].

  Gendon IuZ. Gendon IuZ. Vopr Virusol. 2011 Jan-Feb;56(1):4-17. Vopr Virusol. 2011. PMID: 21427948 Review. Russian.